All Stories

  1. Draft Genome Sequence of an Extended-Spectrum β-Lactamase (CTX-M-15) producing Escherichia coli ST10 Isolated from a Nasal Sample of an Abattoir Worker in Cameroon
  2. Draft Genome Sequencing of Extended Spectrum β-Lactamase Enterobacter aerogenes Isolates from Swine and Human
  3. Community pharmacists-Leaders for antibiotic stewardship in respiratory tract infection
  4. Molecular characterisation of multidrug-resistant P. aeruginosa from a private hospital in Durban, South Africa
  5. A situational analysis of current antimicrobial governance, regulation and utilisation in South Africa
  6. A Review of Moxifloxacin for the Treatment of Drug-Susceptible Tuberculosis
  7. Mechanisms of antibiotic resistance in Haemophilus parainfluenzae
  8. Emerging fluoroquinolone and ketolide resistance in Haemophilus parainfluenzae in South Africa
  9. Effect of rifampicin and efavirenz on moxifloxacin concentrations when co-administered in patients with drug-susceptible TB
  10. Fluoroquinolone, Macrolide, and Ketolide Resistance in Haemophilus parainfluenzae from South Africa
  11. Comparison of Existing Phenotypic and Genotypic Tests for the Detection of NDM and GES Carbapenemase- Producing Enterobacteriaceae
  12. Antibiotic resistance profiles of Campylobacter species in the South Africa private health care sector
  13. Surveillance of antibiotic use in the private sector in Namibia using sales and claims data
  14. Antibiotic Resistance in the Food Chain: A Developing Country-Perspective
  15. Colistin and tigecycline resistance in carbapenemase-producing Gram-negative bacteria: emerging resistance mechanisms and detection methods
  16. Plasmid-mediated resistance and virulence mechanisms in the private health sector in KwaZulu-Natal, South Africa: An investigation of methicillin resistant Staphylococcus aureus (MRSA) clinical isolates collected during a three month period
  17. Antimicrobial susceptibility profiles of Escherichia coli and Klebsiella pneumoniae isolated from outpatients in urban and rural districts of Uganda
  18. In vitroevaluation of metal chelators as potential metallo- β -lactamase inhibitors
  19. Antimicrobial resistance in the WHO African region: current status and roadmap for action
  20. The Molecular Epidemiology and Genetic Environment of Carbapenemases Detected in Africa
  21. Secondary school factors relating to academic success in first-year Health Science students
  22. Public knowledge, attitudes and behaviour towards antibiotic usage in Windhoek, Namibia
  23. Review of established and innovative detection methods for carbapenemase-producing Gram-negative bacteria
  24. NDM-1, novel TEM-205, novel TEM-213 and other extended-spectrum β-lactamases co-expressed in isolates from cystic fibrosis patients from South Africa
  25. Antibiotic use in Namibia: prescriber practices for common community infections
  26. More action, less resistance: report of the 2014 summit of the Global Respiratory Infection Partnership
  27. NOTA: a potent metallo-β-lactamase inhibitor
  28. An evaluation of antibiotic prescribing patterns in adult intensive care units in a private hospital in KwaZulu-Natal
  29. Evaluation of MALDI Biotyping for Rapid Subspecies Identification of Carbapenemase-Producing Bacteria via Protein Profiling
  30. Optimized Microwave Assisted Synthesis of LL37, a Cathelicidin Human Antimicrobial Peptide
  31. Demographic and microbiological profile of cystic fibrosis in Durban, South Africa
  32. Demographic and microbiological profile of cystic fibrosis in Durban, South Africa
  33. A framework for the non-antibiotic management of upper respiratory tract infections: towards a global change in antibiotic resistance
  34. Prescriber and Patient Responsibilities in Treatment of Acute Respiratory Tract Infections — Essential for Conservation of Antibiotics
  35. Models for increasing the health workforce
  36. Observational Study of the Prevalence and Antibiotic Resistance of Campylobacter spp. from Different Poultry Production Systems in KwaZulu-Natal, South Africa
  37. Government funding as leverage for quality teaching and learning
  38. Antibiotic resistance via the food chain: Fact or fiction?
  39. Prevalence of antibiotic resistance in Campylobacter isolates from commercial poultry suppliers in KwaZulu-Natal, South Africa
  40. Characterization of extended-spectrum β-lactamases in Salmonella spp. at a tertiary hospital in Durban, South Africa
  41. CMY-20, a novel AmpC-type β-lactamase from South African clinical Escherichia coli isolates
  42. CTX-M-37 in Salmonella enterica serotype Isangi from Durban, South Africa
  43. Optimisation and characterisation of bioadhesive controlled release tetracycline microspheres
  44. Klebsiella pneumoniae isolate from South Africa with multiple TEM, SHV and AmpC β-lactamases
  45. Complexity and Diversity of Klebsiella pneumoniae Strains with Extended-Spectrum β-Lactamases Isolated in 1994 and 1996 at a Teaching Hospital in Durban, South Africa
  46. Treatment options for extended-spectrum β-lactamase-producers
  47. Treatment options for extended-spectrum β-lactamase-producers
  48. Laboratory detection of extended-spectrum β-lactamases (ESBLs)—The need for a reliable, reproducible method